Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -119.54% is in line with its 5-year average of -111.41%, around the middle of its 5-year range (-208.81%–-1.40%).
15.82% above its 12-month average of -142.00%.
Reported quarterly operating margin; no daily interpolation. Q4 FY2026 (2026-05-31): -175.20%.
OPERATING MARGIN
-119.54%
OPERATING MARGIN AVG TTM
-142.00%
OPERATING MARGIN AVG 3Y
-125.25%
OPERATING MARGIN AVG 5Y
-111.41%
OPERATING MARGIN AVG 10Y
-79.24%
OPERATING MARGIN AVG 15Y
-54.68%
OPERATING MARGIN AVG 20Y
-31.20%
CURRENT VS TTM AVG
+15.82%
CURRENT VS 3Y AVG
+4.56%
CURRENT VS 5Y AVG
-7.30%
CURRENT VS 10Y AVG
-50.86%
CURRENT VS 15Y AVG
-118.61%
CURRENT VS 20Y AVG
-283.09%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 496 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Biomerica, Inc.
Market Cap
$6.34M
Operating Margin
-119.54%
TTM Avg
-142.00%
3Y Avg
-125.25%
5Y Avg
-111.41%
Market Cap
$6.44M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$6.10M
Operating Margin
-763.90%
TTM Avg
-929.35%
3Y Avg
-1043.46%
5Y Avg
-924.75%
Market Cap
$6.10M
Operating Margin
-43737.46%
TTM Avg
-33857.66%
3Y Avg
-147235.02%
5Y Avg
-109633.70%
Market Cap
$6.09M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-71.62%
Market Cap
$6.03M
Operating Margin
-9154.62%
TTM Avg
-6279.74%
3Y Avg
-3924.25%
5Y Avg
-3328.36%
Market Cap
$6.72M
Operating Margin
-450.07%
TTM Avg
-699.99%
3Y Avg
-986.00%
5Y Avg
-5433.17%
Market Cap
$6.74M
Operating Margin
-9312.55%
TTM Avg
-10684.89%
3Y Avg
-9259.36%
5Y Avg
-8523.06%
Market Cap
$6.76M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Biomerica, Inc. (BMRA) | $6.34M | -119.54% | -142.00% | -125.25% | -111.41% |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.44M | 0.00% | 0.00% | 0.00% | 0.00% |
| Femasys Inc. (FEMY)vs › | $6.10M | -763.90% | -929.35% | -1043.46% | -924.75% |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $6.10M | -43737.46% | -33857.66% | -147235.02% | -109633.70% |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $6.09M | 0.00% | 0.00% | 0.00% | -71.62% |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $6.03M | -9154.62% | -6279.74% | -3924.25% | -3328.36% |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.72M | -450.07% | -699.99% | -986.00% | -5433.17% |
| Aclarion, Inc. (ACON)vs › | $6.74M | -9312.55% | -10684.89% | -9259.36% | -8523.06% |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.76M | 0.00% | 0.00% | 0.00% | 0.00% |
| Co-Diagnostics, Inc. (CODX)vs › | $6.88M | -5025.53% | -3024.64% | -1688.76% | -1108.68% |
Gross Margin
8.1%
Operating Margin
-119.5%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-05-31 | -175.20% |
| 2026-02-28 | -131.51% |
| 2025-11-30 | -113.47% |
| 2025-08-31 | -81.01% |
| 2025-05-31 | -208.81% |
| 2025-02-28 | -108.13% |
| 2024-11-30 | -60.70% |
| 2024-08-31 | -75.71% |
| 2024-05-31 | -136.92% |
| 2024-02-29 | -196.66% |
| 2023-11-30 | -102.62% |
| 2023-08-31 | -71.92% |
| 2023-05-31 | -165.65% |
| 2023-02-28 | -148.56% |
| 2022-11-30 | -112.43% |
| 2022-08-31 | -126.41% |
| 2022-05-31 | -33.12% |
| 2022-02-28 | -1.40% |
| 2021-11-30 | -24.31% |
| 2021-08-31 | -122.08% |
| 2021-05-31 | -142.90% |
| 2021-02-28 | -59.67% |
| 2020-11-30 | -124.78% |
| 2020-08-31 | -166.06% |
| 2020-05-31 | -17.90% |
| 2020-02-29 | -77.74% |
| 2019-11-30 | -30.68% |
| 2019-08-31 | -42.66% |
| 2019-05-31 | -65.60% |
| 2019-02-28 | -56.08% |
| 2018-11-30 | -32.38% |
| 2018-08-31 | -35.73% |
| 2018-05-31 | -56.98% |
| 2018-02-28 | -23.47% |
| 2017-11-30 | -17.89% |
| 2017-08-31 | -15.65% |
| 2017-05-31 | -24.25% |
| 2017-02-28 | -21.18% |
| 2016-11-30 | -15.33% |
| 2016-08-31 | -4.65% |
| 2016-05-31 | -20.50% |
| 2016-02-29 | -19.76% |
| 2015-11-30 | -18.01% |
| 2015-08-31 | -5.92% |
| 2015-05-31 | -4.09% |
| 2015-02-28 | -10.43% |
| 2014-11-30 | -22.04% |
| 2014-08-31 | -21.66% |
| 2014-05-31 | -3.45% |
| 2014-02-28 | 2.19% |
| 2013-11-30 | -26.48% |
| 2013-08-31 | -17.14% |
| 2013-05-31 | 1.20% |
| 2013-02-28 | -4.47% |
| 2012-11-30 | 13.14% |
| 2012-08-31 | 18.34% |
| 2012-05-31 | 3.86% |
| 2012-02-29 | 8.88% |
| 2011-11-30 | 12.01% |
| 2011-08-31 | 8.30% |
| 2011-07-29 | -1.27% |
| 2011-02-28 | 5.42% |
| 2010-11-30 | -15.30% |
| 2010-08-31 | -1.04% |
| 2010-05-31 | -12.68% |
| 2010-02-28 | 7.99% |
| 2009-11-30 | -27.84% |
| 2009-08-31 | 0.41% |
| 2009-05-31 | -0.52% |
| 2009-02-28 | 15.59% |
| 2008-11-30 | -9.57% |
| 2008-08-31 | 12.33% |
| 2008-05-31 | 12.85% |
| 2008-02-29 | 9.51% |
| 2007-11-30 | 0.61% |
| 2007-08-31 | 16.00% |
| 2007-05-31 | 13.62% |
| 2007-02-28 | 7.30% |
| 2006-11-30 | 8.64% |
| 2006-08-31 | 3.83% |
| 2006-05-31 | 4.51% |
| 2006-02-28 | 3.70% |
| 2005-11-30 | -4.36% |
| 2005-08-31 | -4.12% |
| 2005-05-31 | -2.52% |
| 2005-02-28 | 2.55% |
| 2004-11-30 | -5.84% |
| 2004-08-31 | -4.72% |
| 2004-05-31 | 1.16% |
| 2004-02-29 | 3.97% |
| 2003-11-30 | -5.69% |
| 2003-08-31 | -14.37% |
| 2003-05-31 | 3.39% |
| 2003-02-28 | -0.07% |
| 2002-11-30 | -6.81% |
| 2002-08-31 | -7.21% |
